Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » In Brief This Week: LineaRx, OncoCyte, Vela Diagnostics, CosmosID, More

In Brief This Week: LineaRx, OncoCyte, Vela Diagnostics, CosmosID, More

Feb 07, 2020
|
staff reporter

NEW YORK – Applied DNA Sciences subsidiary LineaRx said it has expanded an existing joint development agreement with Takis Biotech to include preclinical development of a linear DNA vaccine against 2019-nCoV, the novel coronavirus that originated in Wuhan, China.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

This Time, Novavax

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Shortened Visas for Some Students

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

New York's Own Review

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

Science Papers Examine Y Chromosomes of Archaic Humans, Schistosomiasis Therapeutic Targets

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.

What's Popular?

In Business News

  1. Exact Sciences Stock Soars on New Data Around Pan-Cancer Liquid Biopsy Test

  2. Clear Labs Nanopore Sequencing Coronavirus Test Gets FDA Emergency Use Authorization

  3. Catalog DNA Merges Molecular Biology, Information Theory to Pursue DNA-Based Computing

    Premium

  4. People in the News: New Appointments at Inivata, Exact Sciences, Euformatics, More

  5. Fulgent Inks $125M Equity Distribution Agreement With Piper Sandler

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.